The pink app, which is now being produced by eContinence AB, contains simpler free content and the possibility to upgrade to Premium with new exciting content and new features. Initially the app will not be available in all countries due to the CE marking regulations there. Find out more here
Many pregnant and postnatal women used the freely available app Tät®, both for prevention and treatment of urinary incontinence. 3680 women answered a questionnaire at download and after three months. A majority of those with incontinence experienced improvement after treatment, and regular pelvic floor muscle training and app use were important factors for experiencing improvement. Read more here
The research behind our first app – the Tät® app – is now complete, and that means that the app is no longer financed by government funding for research. For that reason, the doctors and researchers in our team have started up a company to continue to provide and develop the app going forward. Indeed, we believe that everybody should have access to simple and effective treatment, even in the future. We will soon launch a completely new version of the app including simpler free content and the possibility to upgrade to premium, with new content and new features. Initially the app will not be available in all countries due to the CE marking regulations. Read more here
Of the men who trained with the app for three months, 97% felt that it facilitated their training, and the proportion of those who felt that they used the correct muscles when performing muscle contractions increased from 40 to 88%. The study is now published in BJUI Compass and is available to read here
A health economic analysis of the app Tät®II for treatment of mixed and urge urinary incontinence was recently published in the International Urogynecology Journal. The study concludes that the app Tät®II is a new, cost-effective first-line treatment option, and may be a way to reach more women wishing treatment. Read more here
